Your browser doesn't support javascript.
loading
EndoBridge 2023: highlights and pearls.
Yildiz, Bulent Okan; Boguszewski, Cesar Luiz; da Silva Boguszewski, Margaret Cristina; Busetto, Luca; Celik, Ozlem; Fuleihan, Ghada El-Hajj; Goulis, Dimitrios G; Hammer, Gary D; Haymart, Megan R; Kaltsas, Gregory; Law, Jennifer R; Lim, Amanda Yuan Ling; Luger, Anton; Macut, Djuro; McGowan, Barbara; McClung, Michael; Miras, Alexander Dimitri; Patti, Mary Elizabeth; Peeters, Robin P; Pignatelli, Duarte; Saeed, Hamayle; Sipos, Jennifer; Stratakis, Constantine A; Tsoli, Marina; van der Lely, A J; Witchel, Selma F; Yazici, Dilek.
Afiliação
  • Yildiz BO; Division of Endocrinology and Metabolism, Department of Internal Medicine, Hacettepe University School of Medicine, 06100, Hacettepe, Ankara, Turkey. yildizbo@yahoo.com.
  • Boguszewski CL; Department of Internal Medicine, Endocrine Division (SEMPR), University Hospital, Federal University of Parana, Curitiba, Brazil.
  • da Silva Boguszewski MC; Department of Pediatrics, Endocrine Division (SEMPR), University Hospital, Federal University of Parana, Curitiba, Brazil.
  • Busetto L; Department of Medicine, University of Padova, Padova, Italy.
  • Celik O; Department of Endocrinology and Metabolism, School of Medicine, Acibadem University, Istanbul, Turkey.
  • Fuleihan GE; Division of Endocrinology, Deparment of Medicine at the American University of Beirut, Beirut, Lebanon.
  • Goulis DG; Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Hammer GD; Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI, USA.
  • Haymart MR; Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI, USA.
  • Kaltsas G; First Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Law JR; Division of Pediatric Endocrinology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
  • Lim AYL; Imperial College Healthcare NHS Trust, London, UK.
  • Luger A; Division of Endocrinology, Department of Medicine, National University Hospital, Singapore, Singapore.
  • Macut D; Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • McGowan B; Institute of Endocrinology, University of Belgrade, Belgrade, Serbia.
  • McClung M; Guy's and St Thomas Hospital and King's College London, London, UK.
  • Miras AD; Oregon Osteoporosis Center, Portland, OR, USA.
  • Patti ME; School of Medicine, Ulster University, Derry, Londonderry, UK.
  • Peeters RP; Joslin Diabetes Center, Boston, MA, USA.
  • Pignatelli D; Department of Internal Medicine, Academic Center for Thyroid Disease, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Saeed H; Department of Endocrinology, Centro Hospitalar e Universitário de S. João, Porto, Portugal.
  • Sipos J; Joslin Diabetes Center, Boston, MA, USA.
  • Stratakis CA; Division Endocrinology, Diabetes and Metabolism, Ohio State University, Columbus, OH, USA.
  • Tsoli M; Human Genetics & Precision Medicine, IMBB, FORTH, Heraklion & NICHD, NIH, Bethesda, MD, USA.
  • van der Lely AJ; Academic Scholar Fellow at 1st Department of Propaedeutic and Internal Medicine, Laiko Hospital, Athens, Greece.
  • Witchel SF; Pituitary Center Rotterdam and Division of Endocrinology, Department of Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Yazici D; Division of Pediatric Endocrinology, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA.
Hormones (Athens) ; 23(2): 183-204, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38619812
ABSTRACT
EndoBridge 2023 took place on October 20-22, 2023, in Antalya, Turkey. Accredited by the European Council, the 3-day scientific program of the 11th Annual Meeting of EndoBridge included state-of-the-art lectures and interactive small group discussion sessions incorporating interesting and challenging clinical cases led by globally recognized leaders in the field and was well attended by a highly diverse audience. Following its established format over the years, the program provided a comprehensive update across all aspects of endocrinology and metabolism, including topics in pituitary, thyroid, bone, and adrenal disorders, neuroendocrine tumors, diabetes mellitus, obesity, nutrition, and lipid disorders. As usual, the meeting was held in English with simultaneous translation into Russian, Arabic, and Turkish. The abstracts of clinical cases presented by the delegates during oral and poster sessions have been published in JCEM Case Reports. Herein, we provide a paper on highlights and pearls of the meeting sessions covering a wide range of subjects, from thyroid nodule stratification to secondary osteoporosis and from glycemic challenges in post-bariatric surgery to male hypogonadism. This report emphasizes the latest developments in the field, along with clinical approaches to common endocrine issues. The 12th annual meeting of EndoBridge will be held on October 17-20, 2024 in Antalya, Turkey.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças do Sistema Endócrino Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças do Sistema Endócrino Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article